Soydal Çiğdem, Araz Mine, Durmaz Mustafa, Özkan Elgin, Ergüder Berrin İmge, Küçük Nuriye Özlem, Bilgiç Sadık, Elhan Atilla Halil, Geçim İbrahim Ethem
Ankara University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey.
Ankara University Faculty of Medicine, Department of Biochemistry, Ankara, Turkey.
Mol Imaging Radionucl Ther. 2022 Jun 27;31(2):114-122. doi: 10.4274/mirt.galenos.2022.73636.
To analyze the change in circulating angiogenic factor levels after transarterial radioembolization (TARE) for colorectal cancer liver metastases (CRCLMs) and its prognostic significance.
Blood samples immediately before TARE and on 1 day, 1 week and 6 weeks after were collected for angiogenic factor analysis in 23 patients.
Patients with elevated serum basic fibroblast growth factor and platelet-derived growth factor levels in the 1 week and vascular endothelial growth factor (VEGF) levels in the 6 week after TARE had significantly shorter median overall survival (OS) times.
Some early increases in serum angiogenic factor levels and in serum VEGF in the 6 week after TARE for CRCLMs are related to short OS and progression-free survival.
分析经动脉放射性栓塞术(TARE)治疗结直肠癌肝转移(CRCLM)后循环血管生成因子水平的变化及其预后意义。
收集23例患者TARE术前及术后1天、1周和6周的血样进行血管生成因子分析。
TARE术后1周血清碱性成纤维细胞生长因子和血小板衍生生长因子水平升高以及术后6周血管内皮生长因子(VEGF)水平升高的患者,其总生存期(OS)的中位时间显著缩短。
CRCLM患者TARE术后血清血管生成因子水平早期有所升高,且术后6周血清VEGF升高与较短的OS和无进展生存期相关。